Back

Early effects of levosimendan on LV function in patients with CCS and single vessel CTO of the LAD artery

10 May 2026 (14:55 - 16:12)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - pathophysiology and mechanisms (4) Heart Failure with Mid-Range Ejection Fraction (HFmrEF) HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Marufjon Norkulov

Republican Specialized Cardiology Centre - Karshi Branch, Karshi (Uzbekistan)

5 More presentations in this session

Presentation thumbnail
Cardiogenetic Registry: Design and first Results on the prevalence of pathogenic variants in cardiomyopathies
Doctor N. Panagiotides (Vienna, AT)
Abstract Slides
Presentation thumbnail
Hypertensive response to exercise indexed to oxygen consumption: associations with cardio-vascular-renal function and prognosis across the spectrum of heart failure with preserved ejection fraction
Doctor N. De Biase (Pisa, IT)
Abstract Slides
Presentation thumbnail
Impact of non-invasive positive pressure ventilation on pulmonary artery diastolic pressure: a longitudinal physiologic analysis
Doctor R. Germany (Minnetonka, US)
Abstract Slides
Presentation thumbnail
Pilot study on hemodynamic monitoring in patients with advanced heart failure - comparison of non-invasive versus invasive hemodynamic monitoring
Doctor S. Macura (Berlin, DE)
Abstract Slides
Presentation thumbnail
Correlation of NT-proBNP, C-reactive protein, and renal function with left ventricular ejection fraction in HFpEF and HFmrEF
Doctor D. Milosevic (Nis, RS)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure - pathophysiology and mechanisms (4)

The Event

Event poster

Heart Failure 2026

10 May 2026 14:55 CET
You may be interested in
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Webinar
Unmet needs in HF: patients with LVEF equal or above 40%

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources